Program - Thursday, March 9

Print
Please click on the relevant day to view the applicable detailed program. To view the program overview, please click here


  Thursday, March 9    
Wednesday, March 8 Friday, March 10 Saturday, March 11
THURSDAY, MARCH 9, 2017 Hall F
07:00-08:00 National Study Group Session | Croatian and Austrian Study Group
  Croatian and Austrian experts walking the line: from prevention to therapy in diabetic pregnancy
07:00-07:10

Prevalence of gestational diabetes mellitus according to IADPSG and NICE criteria
Josip Djelmis

07:10-07:20 Results from the pan-European intervention trial to prevent GDM: The DALI project
Gernot Desoye
07:20-07:30 The time has come to create the guidelines for treatment of diabetes in pregnancy with OAD in EU Mila Cervar Zivkovic
07:30-07:40 The specifics of different diet pattern on lipid content in placental tissue, maternal and fetal blood Mislav Herman
07:40-07:50 C-peptide in type 1-diabetic pregnant patients
Marina Horvaticek and Marina Ivanisevic
07:50-08:00 Discussion


  Hall D
07:00-08:00 National Study Group Session | Latin American Study Group
Presidente: Dr. Ernesto Castelazzo, Mexico
Coordinador: Dr. Luis Cabero Roura, España
  Expositores o disertantes
1) Dr. Hector Bolatti
, Argentina, Representante Latinoamericano del Working Group DMG – FIGO
2) Dra. Fanny Corrales, Paraguay, Representante FLASOG – Region cono sur
  Temario:
1) Diabetes en America Latina – prevalencia y repercusiones materno fetales
2) Estado actual del diagnóstico. Reflexiones, y perspectivas a futuro
3) Barreras que inciden en el resultado materno – perinatal – propuestas.


  Hall G
07:00-08:00 National Study Group Session | Israeli Study Group 1
Chairpersons: Rony Chen, Israel and Eyal Sheiner, Israel
  Giving Progesterone during multiple pregnancy
  Yes/No: Prof. Yariv Yogev
  Is there a recommended weight loss in pregnancy of obesity?
  Yes: Prof. Eyal Sheiner
  No: Prof. Uriel Elchalal
  Omega-3 treatment in pregnancy - Yes / No?
  Yes: Tamar Harel
  No: Gila Faiman
  Glucose variability and adverse pregnancy outcomes: Tali Cukierman-Yaffe


  Hall E
07:00-08:00 National Study Group Session | Mediterranean Diabetes & Pregnancy Study Group
  Peripartal hysterectomy in, causes and therapy, in diabetic patients Prof Dr Sasa Kadija, Co Director of the Clinic for Gyn and Obst Clinical Centre Serbia, Chief Of the Department for Gynecology, Medical Faculty University Belgrade
  Contemporary approach in the treatment of gynecological malignancies in young patients especially diabetes Prof Dr Katarina Jeremic, Chief of preoperativnu council of the Clinic for Gyn and Obst Clinical Centre Serbia, Medical Faculty University Belgrade
  Fertility sparing procedure in young women with gynecological malignancies Prof Dr Stefanovic Aleksandar, Director of the Clinic for Gyn and Obst Clinical Centre Serbia, Chief of the Operative Ward, Medical Faculty University Belgrade
  Is the deficiency of magnesium a connection for preterm delivery, diabetes, Hypertension? Prof Dr Ana Mitrovic Jovanovic, Chief of Perinatal department, Clinic Gyn Obs Narodni Front, Medical Faculty University Belgrade
  Ultrasonography, contemporary and supplement screening method for gestational diabetes Dr Milan Perovic Research assistant Professor Clinic Gyn Obs Narodni Front, Medical Faculty University Belgrade
  How to practical manage complications of both fetus and Neonatus in all forms of diabetes and in Hypertension Prof Dr Miroslava Gojnic Dugalic, Chief of High Risk Pregnancies, Hypertension and Ward for Diabetes, Clinic for Gyn and Obst Clinical Centre Serbia, Chief of the Operative Ward, Medical Faculty University Belgrade
  Psychophysiological factors affecting glycoregulation in pregnancy: Current status and future prospects: Prof Igor Pantic, Medical Faculty, University of Belgrade


THURSDAY, MARCH 9, 2017
 
Hall C (In Parallel)
07:00-08:00
Despertar en BarcelonaHot Topics in Maternal and Fetal Medicine
Chairpersons: Diego Ayres-de-Campos, Portugal and Apostolos Athanasiadis, Greece
07:00-07:20 Maternal - Obesity and GDM which is the most significant risk factor for preeclampsia
Aris Antsaklis, Greece
07:20-07:40 Fetal - Reducing stillbirths through improved antenatal detection of fetal growth restriction
Jason Gardosi, UK
07:40-08:00 Maternal and Fetal Health Economics – Evaluating Pregnancy Induced Complications
Gabriella Conti, UK 
 
 
Hall A
08:00-09:20
Plenary Session 3 | Buenas Dias Barcelona - Opening Lectures | Innovations, Inventions and Winnovations - Prediction and Preventions of Pregnancy Complications
Chairpersons: Joe Leigh Simpson, USA and Gerard Visser, the Netherlands
08:00-08:20 The IUGR Lecture
Prevention of IUGR - is it really possible?
Irene Cetin, Italy
08:20-08:40
The PET Lecture
Emerging Prevention and Treatment Strategies for Preeclampsia
The PRESERVE1 Trial
Michael Paidas, USA
08:40-09:00 The PTL Lecture
Prevention of preterm birth
Eduardo Fonseca, Brazil
09:00-09:20 The MFM Lecture
Management of gestational diabetes mellitus: costs and cost-effectiveness of pregnancy complications?
Aaron B. Caughey, USA
 
09:20-10:00
Plenary Session 4 | Facing the Non Communicable Disease (NCD) Global Epidemic - It all starts in urtero
Chairpersons: Luis Cabero Roura, Spain;  Gian Carlo Di Renzo, Italy, Andre Van Assche, Belgium and Jacky Nizard, France
09:20-09:40 The Vicious cycle of Pregnancy Induced Complication and Non Communicable Disease – It all starts in Utero. The FIGO Global vision:
CN Purandare, India
   
 09:40-10:40 The European HIP Declaration Ceremony
  Tahir Mahmood, UK, President EBCOG 
  Moshe Hod, Israel, President EAPM
10:40-11:10  Coffee and Refreshment Break
   
 
 
Breakout Sessions
Hall A (In Parallel)
11:10-12:40
Maternal Medicine 5A | New Technologies in Diabetic Pregnancy
Chairpersons: Graziano Di Cianni, Italy and Harold de Valk, the Netherlands
11:10-11:28
New technologies in diabetic pregnancies - Increasing role of automation
Ohad Cohen, Israel
11:28-11:46
Closed-Loop in Diabetic Pregnancy: How much longer do we have to wait?
Helen Murphy, UK
11:46-12:04
Using pumps and CGM during labor
Denice Feig, Canada
12:04-12:22
Mobile decision support in GDM
Mercedes Rigla Cros, Spain
12:22-12:40
Efficacy of continuous glucose monitoring in diabetic pregnancy. the GlucoMOMS trial:
Daphne van Munster, the Netherlands
 
 
Hall B (In Parallel)
11:10-12:40
Maternal Medicine 5B | Obesity, Metabolic Syndrome and Pregnancy
Chairpersons: Liliana Voto, Brazil and Eyal Sheiner, Israel
11:10-11:30
Maternal overweight, obesity and GDM & offspring neurodevelopment
Cristina Campoy, Spain
11:30-11:50
Bariatric surgery: Downsizing pregnancy complications?
Eyal Sheiner, Israel
11:50-12:10
Metabolically healthy and non-healthy obesity in pregnancy
Anunziata Lapolla, Italy
12:10-12:40
Perinatal programming of Obesity - the EaCH study 
Jens Stupin, Germany
 
 
Hall C (In Parallel)
11:10-12:40
Maternal Medicine 5C | FIGO-GDM Initiative towards a Universal Consensus on GDM Management - The Global Scenario
Chairpersons: Hema Divakar, India and Ester Vitacolonna, Italy
11:10-11:25
GDM - an end to procrastination and a time for action - The IADPSG voice
Fidelma Dunne, UK
11:25-11:40
GDM diagnosis - the SMFM approach - is there a way to change?
Mary D'Alton, USA
11:40-11:55
Critical evaluation of the IADPSG implementation studies
Rosa Corcoy, Spain
11:55-12:10
Field testing of the Indian National GDM Guidelines in Madhya Pradesh State
Archana Mishra, India
12:10-12:25
HIP in Nicaragua: Insights and Lessons from the GDM project in Managua
Heather White, USA
12:25-12:40
Do it your way or do it the FIGO way – a pragmatic approach
Moshe Hod, Israel
 
 
Hall D (In Parallel)
11:10-12:40
Fetal Medicine 5D | Fetal Classical and New Infections
Chairpersons: Laurent Mandelbrot, France and Anna Gonce, Spain
11:10-11:30
Current issues with HIV infection:
Laurent Mandelbrot, France
11:30-11:50

Cytomegalovirus:
Eran Hadar, Israel

11:50-12:10
Zika Virus
Gustavo Malinger, Israel
12:10-12:30
Chagas
Anna Gonce, Spain
12:30-12:40 Discussion
 
 
Hall E (In Parallel)
11:10-12:40
Fetal Medicine 5E | Fetal Cardiac Function
Chairpersons: Simcha Yagel, Israel and Fatima Crispi, Spain
11:10-11:30
Myocardial imaging of the fetal heart: Bart Bijnens, Spain
11:30-11:50
TAPSE and 3D/4DUS as adjunct to the functional examination of the fetal heart
Simcha Yagel, Israel
11:50-12:10
Myocardial Performance Index: technique and indications
Edgar Hernandez-Andrade, USA
12:10-12:30 Fetal cardiac remodelling versus function
Fatima Crispi, Spain
12:30-12:40 Discussion
 
 
Hall F (In Parallel)
11:10-12:40
Fetal Medicine 5F | Fetal Growth
Chairpersons: Jason Gardosi, UK and Francesc Figuera, Spain
11:10-11:30 Fetal growth: towards global standards and evidence based strategies for screening and surveillance: Jason Gardosi, UK
11:30-11:50 First trimester screening for fetal growth restriction
Francesc Figueras, Spain
11:50-12:10 Ultrasound strategies to screen for fetal growth problems
Torvid Kiserud, Norway
12:10-12:40 Round Table
 
 
Hall G (In Parallel)
11:10-12:40
Basic Science 5G | The Placenta
INVENTIONS, INNOVATIONS, WINNOVATIONS
Chairpersons: Gernot Desoye, Austria and Apostolos Athanasiadis, Greece
11:10-11:25
Placental miRNAs in pregnancy complications
Noam Shomron, Israel
11:25-11:40
Placental lipid transfer and metabolism: Does it play a role for neonatal adiposity?
Gernot Desoye, Austria
11:40-11:55
Placental perfusion and metabolism in GDM
Jose Louis Bartha, Spain
11:55-12:10
Metabolomics in healthy and diabetic pregnancies
M Pilar Ramos, Spain
12:10-12:25
Maternal and cord blood metabolic markers in GDM
Ana Megía, Spain
12:25-12:40
Maternal and fetal lipid metabolism under normal and gestational diabetes conditions
Emilio Herrera, Spain
 
Parallel Sessions
Hall A
12:40-14:10
Maternal Medicine Session 6 | From Diabetes in Pregnancy to Diabetes After Pregnancy
Chairpersons: Boyd Metzger, USA and Luis Felipe Pallardo, Spain
12:40-12:55 The HAPO FUS - Update and preliminary results
Boyd Metzger, USA
12:55-13:10 From DIP to DAP: Addressing the prevention of diabetes after pregnancy
Kaberi Dasgupta, Canada
13:10-13:25 Gestational diabetes mellitus and life span outcome for the child
Asnat Walfisch, Israel
13:25-13:40 Can intervention with the GLP-1-analog Liragutide prevent deterioration in glucose tolerance in women with previous gestational diabetes - 1 year results from an RCT
Signe Foghsgaard, Denmark
13:40-13:55 Gestational Diabetes Mellitus can be prevented by lifestyle intervention: The Finnish Gestational Diabetes Prevention Study (RADIEL)
Saila B. Koivusalo
13:55-14:10 Discussion
 
 
Hall B
12:40-14:10
Fetal Medicine Session 7 | Applications of MRI in Maternal-Fetal Medicine
Chiarpersons: Laurent Salomon, France and Elisenda Eixarch, Spain
12:40-13:00
Brief Update: MRI modes applicable in pregnancy
Elisenda Eixarch, Spain
13:00-13:20
MRI in CNS evaluation: obliged or optional
Gustavo Malinger, Israel
13:20-13:40
Placental MRI: from accreta to placental insufficiency
Laurent Salomon, France
13:40-14:00
Main accepted indication for fetal MRI in fetal defects
Elisenda Eixarch, Spain
14:00-14:10 Discussion
 
14:10-15:00 Lunch Session and Break
 
 
Hall C (in Parallel)
14:10-15:00
Lunch Session A | ASPECTOS RELEVANTES DE LA PRÁCTICA CLÍNICA (1): DIAGNÓSTICO PRENATAL Y PREMATURIDAD
14:10-14:25 DNA libre y array genético: ¿sistemático o en casos seleccionados?
Jose Luis Bartha, Spain
14:25-14:40 Screening de prematuridad sistemático en segundo trimestre ¿Es coste-efectivo?
Nuria Banos, Spain 
14:40-14:55 Nuevas evidencias sobre corticoides por encima de 34 semanas: beneficios y riesgos
Montse Palacio, Spain
 
 
Hall D (in Parallel)
14:10-15:00
Lunch Session B | European Study Group of EASD  
Chairpersons: Angela Napoli, Italy and  Ulf Eriksson, Sweden

Milestones on the History of Diabetes and Pregnancy
Alberto de Leiva, Spain

<spanstyle="line-height:>Obesity and GDM in pregnancy: which intervention for prevention?
Annunziata Lapolla, Italy

Mode of delivery and Treatment with Broadspectrum Antibiotics Affect the Risk of Childhood Type 1 diabetes
Tine Dalsgaard Clausen, Denmark
 
 
Hall E (in Parallel)
14:10-15:00
INDUSTRIAL LUNCH PRESENTATION
To view the program click here
 
 
Hall A
15:00-16:30
Plenary Session 8 | Prediction and prevention of preterm labor 
Chairpersons: Eduardo Fonseca, Brazil and Gian Carlo Di Renzo, Italy
15:00-15:20
Genetic factors in preterm birth           
Joe Leigh Simpson, USA
15:20-15:40
Progesterone in PTB: pharmacodynamics and route of administration
Paul Piette, Belgium
15:40-16:00
Preventive tools in selected high risk patients:where we stand now?
Eduardo Fonseca, Brazil
16:00-16:20
The fate of the preterm newborn and the DOhAD concept
Umberto Simeoni, Switzerland
16:20-16:30 Discussion
 
16:30-17:00 Coffee and Refreshment Break and Poster Session
 
 
Hall A
17:00-18:30
Maternal & Fetal Medicine Session 9 | Managing PL and PROM: Roles for imaging and biomarkers
Chairpersons: Vincenzo Berghella, USA and Montse Palacio, Spain
17:00-17:18 Ultrasound cervical assessment: Current evidences for clinical management
Vincenzo Berghella, USA
17:18-17:36 <spanstyle="line-height:>Imaging Biomarkers: Non invasive ultrasound assessment of fetal lung maturity
Montse Palacio, Spain
17:36-17:54 New imaging modes of the cervix: are we already there?
Edgar Hernandez-Andrade, USA
 17:54-18:12 Biomarkers: Subclinical intra-amniotic inflammation should determine clinical management?
Teresa Cobo, Spain
 17:12-18:30 Biomarkers: Prospects for non-invasive sampling of the intrauterine environment in women with PTL
Bo Jacobsson, Sweden
 
 
Hall B
17:00-18:30
Fetal Medicine Session 10 | Main topics in the Diagnosis and Assessment of Fetal CNS Defects
Chairpersons: Gustavo Malinger, Israel and Elisenda Eixarch, Spain
17:00-17:20 First trimester evaluation of the CNS
Rabih Chaoui, Germany 
17:20-17:40 Assessment of cortical development: methods and clinical use
Miriam Perez-Cruz, Spain
17:40-18:00 Posterior fossa: a systematic approach
Elisenda Eixarch, Spain
18:00-18:20 CNS findings and significance in CMV infection
Gustavo Malinger, Israel
18:20-18:30 Discussion
 
 
Hall D
18:30-20:00
Plenary Session 11 | Beunas Noches Barcelona - SMFM Best Practice Advice in Maternal Fetal Medicine
Chairpersons:
SMFM: Vincenzo Berghella, USA and Mary D'Alton, USA
DIP: Gerard Visser, The Netherlands and Yariv Yogev, Israel
18:30-18:40
1. Don’t do an inheritedthrombophilia evaluation for women with histories of pregnancy loss,intrauterine growth restriction (IUGR), preeclampsia and abruption
Mary D'Alton, USA
18:40-18:50
2. Don’t place a cerclage in women with short cervix who are pregnant with twins
Vincenzo Berghella, USA
18:50-19:00
3. Don’t screen for intrauterine growth restriction (IUGR) with Doppler blood flow studies.
Mary D'Alton, USA
19:00-19:10
4. Don’t use progestogens for preterm birth prevention in uncomplicated multifetal gestations.
Gerard Visser, The Netherlands
19:10-19:20
5. Don’t perform routine cervical length screening for preterm birth risk assessment in asymptomatic women before 16 weeks of gestation or beyond 24 weeks of gestation. Vincenzo Berghella, USA
19:20-19:30
6. Don’t perform antenatal testing on women with the diagnosis of gestational diabetes who are well controlled and without other indications for testing
Yariv Yogev, Israel
19:30-19:40
7. Don’t place women, even those at high-risk, on activity restriction to prevent preterm birth.
Gerard Visser, The Netherlands
19:40-19:50
8. Administer betamethasone for impending preterm labor up to 35 weeks of gestation.
Yariv Yogev, Israel
19:50-20:00
Disucssion




3. Don’t screen for intrauterine growth restriction (IUGR) with Doppler blood flow studies.
Mary D'Alton, USA
3. Don’t screen for intrauterine growth restriction (IUGR) with Doppler blood flow studies.
Mary D'Alton, USA
5. Don’t perform routine cervical length screening for preterm birth risk assessment in asymptomatic women before 16 weeks of gestation or beyond 24 weeks of gestation. Vincenzo Berghella, USA
5. Don’t perform routine cervical length screening for preterm birth risk assessment in asymptomatic women before 16 weeks of gestation or beyond 24 weeks of gestation. Vincenzo Berghella, USA
6. Don’t perform antenatal testing on women with the diagnosis of gestational diabetes who are well controlled and without other indications for testing
Yariv Yogev, Israel
Croatian and Austrian experts walking the line: from prevention to therapy in diabetic pregnancy